Journal article
Human perforin mutations and susceptibility to multiple primary cancers
JA Trapani, KYT Thia, M Andrews, ID Davis, C Gedye, P Parente, S Svobodova, J Chia, K Browne, IG Campbell, WA Phillips, I Voskoboinik, JS Cebon
Oncoimmunology | TAYLOR & FRANCIS INC | Published : 2013
DOI: 10.4161/onci.24185
Abstract
Loss-of-function mutations in the gene coding for perforin (PRF1) markedly reduce the ability of cytotoxic T lymphocytes and natural killer cells to kill target cells, causing immunosuppression and impairing immune regulation. In humans, nearly half of the cases of Type 2 familial hemophagocytic lymphohistiocytosis are due to bi-allelic PRF1 mutations. The partial inactivation of PRF 1 due to mutations that promote protein misfolding or the common hypomorphic allele coding for the A91V substitution have been associated with lymphoid malignancies in childhood and adolescence. To investigate whether PRF1 mutations also predispose adults to cancer, we genotyped 566 individuals diagnosed with me..
View full abstractGrants
Funding Acknowledgements
We acknowledge support from the National Health and Medical Research Council (NHMRC), Melanoma Research Alliance (MRA), Victorian Cancer Agency (VCA), the Victorian State Government Operational Infrastructure Support Program and the NHMRC Independent Research Institutes Infrastructure Support Scheme.